Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.
Ghimire S, Van't Boveneind-Vrubleuskaya N, Akkerman OW, de Lange WC, van Soolingen D, Kosterink JG, van der Werf TS, Wilffert B, Touw DJ, Alffenaar JW. Ghimire S, et al. Among authors: van der werf ts, van soolingen d, van t boveneind vrubleuskaya n. J Antimicrob Chemother. 2016 Oct;71(10):2691-703. doi: 10.1093/jac/dkw164. Epub 2016 May 26. J Antimicrob Chemother. 2016. PMID: 27231277 Review.
The impact of nontuberculous mycobacteria on management of presumed pulmonary tuberculosis.
van Crevel R, de Lange WC, Vanderpuye NA, van Soolingen D, Hoogkamp-Korstanje JA, van Deuren KM, Kullberg BJ, van Herwaarden C, van der Meer JW. van Crevel R, et al. Among authors: van soolingen d, van deuren km, van herwaarden c, van der meer jw. Infection. 2001 Mar-Apr;29(2):59-63. doi: 10.1007/s15010-001-0101-6. Infection. 2001. PMID: 11339476
Isoniazid resistant TB and non-compliance.
van Altena R, van Soolingen D, van der Werf TS. van Altena R, et al. Among authors: van der werf ts, van soolingen d. Thorax. 2004 Dec;59(12):1098; author reply 1098-9. Thorax. 2004. PMID: 15563712 Free PMC article. No abstract available.
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
Bakker-Woudenberg IA, van Vianen W, van Soolingen D, Verbrugh HA, van Agtmael MA. Bakker-Woudenberg IA, et al. Among authors: van soolingen d, van agtmael ma, van vianen w. Antimicrob Agents Chemother. 2005 Jun;49(6):2387-98. doi: 10.1128/AAC.49.6.2387-2398.2005. Antimicrob Agents Chemother. 2005. PMID: 15917538 Free PMC article.
Mycobacterium xenopi clinical relevance and determinants, the Netherlands.
van Ingen J, Boeree MJ, de Lange WC, Hoefsloot W, Bendien SA, Magis-Escurra C, Dekhuijzen R, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d. Emerg Infect Dis. 2008 Mar;14(3):385-9. doi: 10.3201/eid1403.061393. Emerg Infect Dis. 2008. PMID: 18325251 Free PMC article.
Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis.
Alffenaar JW, de Vries PM, Luijckx GJ, van Soolingen D, van der Werf TS, van Altena R. Alffenaar JW, et al. Among authors: van altena r, van der werf ts, van soolingen d. Antimicrob Agents Chemother. 2008 Jun;52(6):2293-5. doi: 10.1128/AAC.01637-07. Epub 2008 Mar 24. Antimicrob Agents Chemother. 2008. PMID: 18362186 Free PMC article. No abstract available.
496 results